Beam Therapeutics Inc. Annual Return On Equity in % from 2019 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Beam Therapeutics Inc. quarterly/annual Return On Equity history and growth rate from 2019 to 2023.
  • Beam Therapeutics Inc. Return On Equity for the quarter ending September 30, 2024 was -16.2 %, a 60.1% increase year-over-year.
  • Beam Therapeutics Inc. annual Return On Equity for 2023 was -15.9 %, a 57.7% increase from 2022.
  • Beam Therapeutics Inc. annual Return On Equity for 2022 was -37.6 %, a 32.8% increase from 2021.
  • Beam Therapeutics Inc. annual Return On Equity for 2021 was -55.9 %, a 32.6% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -15.9 +21.7 +57.7% Jan 1, 2023 Dec 31, 2023
2022 -37.6 +18.3 +32.8% Jan 1, 2022 Dec 31, 2022
2021 -55.9 +27.1 +32.6% Jan 1, 2021 Dec 31, 2021
2020 -83 -131 -274% Jan 1, 2020 Dec 31, 2020
2019 47.6 Jan 1, 2019 Dec 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.